7.40
전일 마감가:
$7.55
열려 있는:
$7.52
하루 거래량:
3.96M
Relative Volume:
0.62
시가총액:
$1.20B
수익:
$1.08B
순이익/손실:
$422.82M
주가수익비율:
3.2456
EPS:
2.28
순현금흐름:
$-637.33M
1주 성능:
-2.37%
1개월 성능:
+12.80%
6개월 성능:
-5.97%
1년 성능:
-41.59%
노바백스 Stock (NVAX) Company Profile
명칭
Novavax Inc
전화
240-268-2000
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
NVAX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NVAX
Novavax Inc
|
7.40 | 1.23B | 1.08B | 422.82M | -637.33M | 2.28 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
노바백스 Stock (NVAX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-08-28 | 재개 | H.C. Wainwright | Buy |
2025-08-20 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2025-06-17 | 개시 | Citigroup | Sell |
2025-02-28 | 개시 | BTIG Research | Buy |
2024-07-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2024-05-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
2024-05-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
2023-08-09 | 업그레이드 | B. Riley Securities | Neutral → Buy |
2023-04-20 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
2023-03-01 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
2023-01-09 | 재확인 | B. Riley Securities | Buy |
2022-12-30 | 재확인 | H.C. Wainwright | Buy |
2022-12-02 | 개시 | Jefferies | Hold |
2022-09-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2022-05-20 | 개시 | BofA Securities | Underperform |
2022-02-23 | 재확인 | B. Riley Securities | Buy |
2022-02-22 | 재개 | Jefferies | Buy |
2022-01-21 | 개시 | Cowen | Outperform |
2021-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-12-14 | 개시 | Jefferies | Buy |
2020-08-06 | 재확인 | H.C. Wainwright | Buy |
2020-08-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
2020-08-05 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
2020-07-16 | 재확인 | H.C. Wainwright | Buy |
2020-07-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2020-06-29 | 재확인 | B. Riley FBR | Buy |
2020-06-29 | 재확인 | H.C. Wainwright | Buy |
2020-06-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
2020-05-28 | 재확인 | B. Riley FBR | Buy |
2020-05-12 | 재확인 | H.C. Wainwright | Buy |
2020-04-30 | 재확인 | H.C. Wainwright | Buy |
2019-11-27 | 재개 | B. Riley FBR | Buy |
2019-08-14 | 재확인 | H.C. Wainwright | Buy |
2019-02-28 | 다운그레이드 | Piper Jaffray | Overweight → Underweight |
2018-12-18 | 개시 | Ladenburg Thalmann | Buy |
2018-12-11 | 개시 | Oppenheimer | Outperform |
2018-11-26 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2018-09-21 | 업그레이드 | JP Morgan | Underweight → Overweight |
2018-03-29 | 업그레이드 | Seaport Global Securities | Neutral → Buy |
모두보기
노바백스 주식(NVAX)의 최신 뉴스
Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success - Seeking Alpha
Is Novavax Inc. forming a reversal patternStock Surge & Safe Entry Momentum Tips - Newser
Short interest data insights for Novavax Inc.July 2025 Trends & Safe Capital Growth Tips - Newser
Novavax to Participate in the Cantor Global Healthcare Conference - MarketScreener
Novavax Inc. stock daily chart insightsWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
Leading Vaccine Developer Novavax to Share Latest Updates at Major Cantor Healthcare Conference in NYC - Stock Titan
Is Novavax Inc. stock entering bullish territoryWeekly Trade Recap & Community Verified Trade Signals - Newser
What machine learning models say about Novavax Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Analyzing Novavax Inc. with multi timeframe chartsWeekly Trend Summary & Weekly Top Gainers Alerts - Newser
What to expect from Novavax Inc. in the next 30 daysCPI Data & Fast Moving Trade Plans - Newser
Is Novavax Inc. trending in predictive chart modelsQuarterly Profit Summary & Fast Momentum Entry Tips - Newser
Combining price and volume data for Novavax Inc.Entry Point & Consistent Growth Equity Picks - Newser
Novavax Inc. recovery potential after sell offEarnings Growth Report & Pattern Based Trade Signal System - Newser
How high can Novavax Inc. stock goJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
How moving averages guide Novavax Inc. trading2025 Top Decliners & Intraday High Probability Alerts - Newser
What to do if you’re stuck in Novavax Inc.Market Trend Summary & Fast Gain Swing Alerts - Newser
How to monitor Novavax Inc. with trend dashboardsPrice Action & Risk Managed Investment Signals - Newser
Candlestick signals on Novavax Inc. stock todayJobs Report & Community Consensus Trade Signals - Newser
Will Novavax Inc. benefit from AI trendsMarket Risk Summary & Community Supported Trade Ideas - khodrobank.com
Is Novavax Inc. exposed to currency risksJuly 2025 Levels & AI Powered Market Trend Analysis - khodrobank.com
What is Novavax Inc.’s TAM (Total Addressable Market)July 2025 Reactions & Stock Market Timing Techniques - khodrobank.com
Why Novavax Inc. stock attracts strong analyst attentionTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser
Using data filters to optimize entry into Novavax Inc.Sell Signal & Daily Oversold Stock Bounce Ideas - Newser
Will Novavax Inc. stock go up soonJuly 2025 Snapshot & Consistent Income Trade Recommendations - Newser
Novavax Inc.’s volatility index tracking explainedJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
Detecting support and resistance levels for Novavax Inc.Earnings Risk Summary & Short-Term Trading Alerts - Newser
Using RSI to spot recovery in Novavax Inc.2025 Price Action Summary & Smart Investment Allocation Tips - Newser
Full technical analysis of Novavax Inc. stockWeekly Trade Recap & High Accuracy Trade Alerts - Newser
Tools to monitor Novavax Inc. recovery probabilityJuly 2025 Levels & Expert Verified Movement Alerts - Newser
Novavax Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - newsyoung.net
Can technical indicators confirm Novavax Inc.’s reversalMarket Risk Summary & Safe Capital Growth Stock Tips - Newser
Will Novavax Inc. benefit from macro trendsIPO Watch & Technical Entry and Exit Tips - Newser
노바백스 (NVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
노바백스 주식 (NVAX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
자본화:
|
볼륨(24시간):